{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:46:04Z","timestamp":1793792764544,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01160-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:28:46Z","timestamp":1762529326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing the schedule of BNT162b2 COVID-19 against long COVID and associated quality of life losses"],"prefix":"10.1038","volume":"5","author":[{"given":"Paul","family":"Kuodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2391-2160","authenticated-orcid":false,"given":"Haneen","family":"Shibli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Zayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Wertheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Beiruti","family":"Wiegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2463-7105","authenticated-orcid":false,"given":"Kamal Abu","family":"Jabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiel A.","family":"Dror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Nazzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-5845","authenticated-orcid":false,"given":"Daniel","family":"Glikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Charlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-0806","authenticated-orcid":false,"given":"Michael","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1160_CR1","unstructured":"World Health Organization. Post COVID-19 condition (long COVID). https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition (2022)."},{"key":"1160_CR2","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. & Diaz, J. V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1160_CR3","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 226, 1593\u20131607 (2022).","journal-title":"J. Infect. Dis."},{"key":"1160_CR4","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z., Xie, Y. & Bowe, B. Long COVID: science, research and policy. Nat. Med. 30, 2148\u20132164 (2024).","journal-title":"Nat. Med."},{"key":"1160_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1160_CR6","doi-asserted-by":"crossref","unstructured":"Kuodi, P., Gorelik, Y., Gausi, B., Bernstine, T. & Edelstein, M. Characterisation of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: a systematic review and meta-analysis. Int. J. Infect. Dis. 134, 1\u20137 (2023).","DOI":"10.1016\/j.ijid.2023.05.003"},{"key":"1160_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1473-3099(23)00053-1","volume":"23","author":"A Iwasaki","year":"2023","unstructured":"Iwasaki, A. & Putrino, D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 23, 393\u2013395 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1160_CR8","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank, Z. et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis. 76, e487\u2013e490 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"1160_CR9","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","volume":"12","author":"AD Proal","year":"2021","unstructured":"Proal, A. D. & VanElzakker, M. B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 (2021).","journal-title":"Front. Microbiol."},{"key":"1160_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00296-022-05146-9","volume":"42","author":"S Zubchenko","year":"2022","unstructured":"Zubchenko, S., Kril, I., Nadizhko, O., Matsyura, O. & Chopyak, V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol. Int. 42, 1523\u20131530 (2022).","journal-title":"Rheumatol. Int."},{"key":"1160_CR11","doi-asserted-by":"crossref","unstructured":"Peluso, M. J. et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Invest. 133, e163669 (2023).","DOI":"10.1172\/JCI163669"},{"key":"1160_CR12","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.jtauto.2021.100100","volume":"4","author":"G Wallukat","year":"2021","unstructured":"Wallukat, G. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 4, 100100 (2021).","journal-title":"J. Transl. Autoimmun."},{"key":"1160_CR13","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso, M. J. & Deeks, S. G. Mechanisms of long COVID and the path toward therapeutics. Cell 187, 5500\u20135529 (2024).","journal-title":"Cell"},{"key":"1160_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","volume":"114","author":"C Zheng","year":"2022","unstructured":"Zheng, C. et al. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int. J. Infect. Dis. 114, 252\u2013260 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"1160_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jinf.2021.12.035","volume":"84","author":"AR Marra","year":"2022","unstructured":"Marra, A. R. et al. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis. J. Infect. 84, 297\u2013310 (2022).","journal-title":"J. Infect."},{"key":"1160_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1160_CR17","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.jaut.2021.102792","volume":"127","author":"A Haque","year":"2022","unstructured":"Haque, A. & Pant, A. B. Mitigating COVID-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. J. Autoimmun. 127, 102792 (2022).","journal-title":"J. Autoimmun."},{"key":"1160_CR18","unstructured":"Huang, Y.-Z. & Kuan, C.-C. Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 26, 1770\u20131776 (2022)."},{"key":"1160_CR19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin, E. G. et al. Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N. Engl. J. Med. 385, e84 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1160_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"YM Bar-On","year":"2021","unstructured":"Bar-On, Y. M. et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N. Engl. J. Med. 385, 1393\u20131400 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1160_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1473-3099(23)00122-6","volume":"23","author":"R Arbel","year":"2023","unstructured":"Arbel, R. et al. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study. Lancet Infect. Dis. 23, 914\u2013921 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1160_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","volume":"387","author":"S Chalkias","year":"2022","unstructured":"Chalkias, S. et al. A bivalent Omicron-containing booster vaccine against COVID-19. N. Engl. J. Med. 387, 1279\u20131291 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1160_CR23","doi-asserted-by":"publisher","first-page":"e000385","DOI":"10.1136\/bmjmed-2022-000385","volume":"2","author":"O Byambasuren","year":"2023","unstructured":"Byambasuren, O., Stehlik, P., Clark, J., Alcorn, K. & Glasziou, P. Effect of COVID-19 vaccination on long COVID: systematic review. BMJ Med. 2, e000385 (2023).","journal-title":"BMJ Med."},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","volume":"41","author":"A Watanabe","year":"2023","unstructured":"Watanabe, A., Iwagami, M., Yasuhara, J., Takagi, H. & Kuno, T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine 41, 1783\u20131790 (2023).","journal-title":"Vaccine"},{"key":"1160_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43058-1","volume":"13","author":"P Kuodi","year":"2023","unstructured":"Kuodi, P. et al. Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel. Sci. Rep. 13, 15801 (2023).","journal-title":"Sci. Rep."},{"key":"1160_CR26","doi-asserted-by":"crossref","unstructured":"Sigfrid, L. et al. What is the recovery rate and risk of long-term consequences from COVID-19?\u2014a harmonised, global observational study protocol. BMJ Open 11, e043887 (2021).","DOI":"10.1136\/bmjopen-2020-043887"},{"key":"1160_CR27","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727\u20131736 (2011).","journal-title":"Qual. Life Res."},{"key":"1160_CR28","unstructured":"Devlin, N. & Parkin, D. in EQ-5D Value Sets: Inventory, Comparative Review and User Guide 39\u201352 (Springer, 2007)."},{"key":"1160_CR29","first-page":"99","volume":"66","author":"AW Hightower","year":"1988","unstructured":"Hightower, A. W., Orenstein, W. A. & Martin, S. M. Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy. Bull. World Health Organ. 66, 99 (1988).","journal-title":"Bull. World Health Organ."},{"key":"1160_CR30","first-page":"2100096","volume":"26","author":"KA Jabal","year":"2021","unstructured":"Jabal, K. A. et al. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 26, 2100096 (2021).","journal-title":"Euro Surveill."},{"key":"1160_CR31","unstructured":"Bates, D., Maechler, M. & Bolker, B. lme4: linear mixed-effects models using S4 classes. R package version 0.999999-0 (R Project, 2012)."},{"key":"1160_CR32","unstructured":"StataCorp LP. Stata Data Analysis and Statistical Software. Special Edition Release (StataCorp LP, 2007)."},{"key":"1160_CR33","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2213-2600(24)00082-1","volume":"12","author":"NTH Trinh","year":"2024","unstructured":"Trinh, N. T. H. et al. Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. Lancet Respir. Med. 12, e33\u2013e34 (2024).","journal-title":"Lancet Respir. Med."},{"key":"1160_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-2600(23)00414-9","volume":"12","author":"M Catal\u00e0","year":"2024","unstructured":"Catal\u00e0, M. et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 12, 225\u2013236 (2024).","journal-title":"Lancet Respir. Med."},{"key":"1160_CR35","doi-asserted-by":"publisher","first-page":"2300690","DOI":"10.2807\/1560-7917.ES.2024.29.35.2300690","volume":"29","author":"M \u0160m\u00edd","year":"2024","unstructured":"\u0160m\u00edd, M. et al. Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023. Euro Surveill. 29, 2300690 (2024).","journal-title":"Euro Surveill."},{"key":"1160_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52925-4","volume":"14","author":"ME Romero-Ibarguengoitia","year":"2024","unstructured":"Romero-Ibarguengoitia, M. E. et al. Association of vaccine status, reinfections, and risk factors with Long COVID syndrome. Sci. Rep. 14, 2817 (2024).","journal-title":"Sci. Rep."},{"key":"1160_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30583-2","volume":"13","author":"B Abu Hamdh","year":"2023","unstructured":"Abu Hamdh, B. & Nazzal, Z. A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci. Rep. 13, 4896 (2023).","journal-title":"Sci. Rep."},{"key":"1160_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annepidem.2024.02.007","volume":"92","author":"C MacCallum-Bridges","year":"2024","unstructured":"MacCallum-Bridges, C. et al. The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020\u20132022. Ann. Epidemiol. 92, 17\u201324 (2024).","journal-title":"Ann. Epidemiol."},{"key":"1160_CR39","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg, Y. et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N. Engl. J. Med. 386, 2201\u20132212 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1160_CR40","doi-asserted-by":"crossref","unstructured":"Romeiser, J. L. & Schoeneck, K. COVID-19 booster vaccination status and long COVID in the United States: a nationally representative cross-sectional study. Vaccines 12, 688 (2024).","DOI":"10.3390\/vaccines12060688"},{"key":"1160_CR41","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.cell.2022.09.032","volume":"185","author":"CM Buckner","year":"2022","unstructured":"Buckner, C. M. et al. Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses. Cell 185, 4333\u20134346 (2022).","journal-title":"Cell"},{"key":"1160_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34961-8","volume":"13","author":"S Dedroogh","year":"2023","unstructured":"Dedroogh, S. et al. Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults. Sci. Rep. 13, 9036 (2023).","journal-title":"Sci. Rep."},{"key":"1160_CR43","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jiph.2023.05.037","volume":"16","author":"S AlBahrani","year":"2023","unstructured":"AlBahrani, S. et al. Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers. J. Infect. Public Health 16, 1276\u20131280 (2023).","journal-title":"J. Infect. Public Health"},{"key":"1160_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/vaccines12020189","volume":"12","author":"MA Man","year":"2024","unstructured":"Man, M. A. et al. Impact of pre-infection COVID-19 vaccination on the incidence and severity of post-COVID syndrome: a systematic review and meta-analysis. Vaccines 12, 189 (2024).","journal-title":"Vaccines"},{"key":"1160_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-5-70","volume":"5","author":"AS Pickard","year":"2007","unstructured":"Pickard, A. S., Neary, M. P. & Cella, D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes 5, 1\u20138 (2007).","journal-title":"Health Qual. Life Outcomes"},{"key":"1160_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1586\/14737167.2014.894462","volume":"14","author":"S Coretti","year":"2014","unstructured":"Coretti, S., Ruggeri, M. & McNamee, P. The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev. Pharmacoecon. Outcomes Res. 14, 221\u2013233 (2014).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"1160_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50024-4","volume":"14","author":"Y Kim","year":"2024","unstructured":"Kim, Y., Bae, S., Chang, H. H. & Kim, S. W. Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study. Sci. Rep. 14, 854 (2024).","journal-title":"Sci. Rep."},{"key":"1160_CR48","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","volume":"27","author":"B Blomberg","year":"2021","unstructured":"Blomberg, B. et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 27, 1607\u20131613 (2021).","journal-title":"Nat. Med."},{"key":"1160_CR49","doi-asserted-by":"crossref","unstructured":"Speiser, D. E. & Bachmann, M. F. COVID-19: mechanisms of vaccination and immunity. Vaccines 8, 404 (2020).","DOI":"10.3390\/vaccines8030404"},{"key":"1160_CR50","doi-asserted-by":"publisher","first-page":"745758","DOI":"10.3389\/fcvm.2021.745758","volume":"8","author":"S Charfeddine","year":"2021","unstructured":"Charfeddine, S. et al. Long COVID-19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from the TUN-EndCOV study. Front. Cardiovasc. Med. 8, 745758 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1160_CR51","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","volume":"41","author":"P Libby","year":"2020","unstructured":"Libby, P. & L\u00fcscher, T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 41, 3038\u20133044 (2020).","journal-title":"Eur. Heart J."},{"key":"1160_CR52","doi-asserted-by":"crossref","unstructured":"Jara, A. et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study. Lancet Reg. Health Am. 21, 100487 (2023).","DOI":"10.1016\/j.lana.2023.100487"},{"key":"1160_CR53","doi-asserted-by":"publisher","first-page":"ofad493","DOI":"10.1093\/ofid\/ofad493","volume":"10","author":"ML Bosworth","year":"2023","unstructured":"Bosworth, M. L. et al. Risk of new-onset long COVID following reinfection with SARS-CoV-2: a community-based cohort study. Open Forum Infect. Dis. 10, ofad493 (2023).","journal-title":"Open Forum Infect. Dis."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01160-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:17:09Z","timestamp":1762535829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01160-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01160-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}